Balaji Amines Limited (NSE:BALAMINES)

Market Cap	47.18B
Revenue (ttm)	13.71B
Net Income (ttm)	1.52B
Shares Out	n/a
EPS (ttm)	46.99
PE Ratio	31.00
Forward PE	21.58
Dividend	11.00 (0.76%)
Ex-Dividend Date	Aug 1, 2025

Volume	22,025
Average Volume	51,465
Open	1,477.60
Previous Close	1,477.60
Day's Range	1,450.00 - 1,489.40
52-Week Range	1,127.55 - 2,433.00
Beta	0.61
RSI	31.38
Earnings Date	Aug 8, 2025

About Balaji Amines

Balaji Amines Limited engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India. The company operates in two segments, Chemicals and Hotel. It offers monomethylamine, dimethylamine, trimethylamine, monoethylamine, diethylamine, triethylamine, and dimethyl and diethyl amino ethanol; and specialty chemicals, including N-methyl pyrrolidone, morpholine, 2-pyrrolidone, N-ethyl-2-pyrrolidone, gamma-butyrolactone, dimethylformamide, acetonitrile, dimethylcarbonate, propylene...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1988
• Employees: 1,169
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BALAMINES

Financial Performance

In 2024, Balaji Amines's revenue was 13.97 billion, a decrease of -14.89% compared to the previous year's 16.42 billion. Earnings were 1.58 billion, a decrease of -23.11%.